sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Neglected Tropical Diseases Drugs And Vaccines Market Scope And Analysis

  • Report Code : TIPRE00005216
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato dei farmaci e dei vaccini per le malattie tropicali neglette e dei concorrenti entro il 2025-2031

Buy Now

Neglected Tropical Diseases Drugs and Vaccines Market Report Neglected Tropical Diseases Drugs and Vaccines Market Size and Share Neglected Tropical Diseases Drugs and Vaccines Market Scope and Analysis

Neglected Tropical Diseases Drugs and Vaccines Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Malattie
  • Malaria
  • Ebola
  • Dengue
  • Chagas
  • Leishmaniosi
  • Virus Zika
By Prodotto
  • farmaci
  • vaccini
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc
  • Sanofi Pasteur
  • Eisai Co., Ltd
  • SABIN VACCINE INSTITUTE
  • Merck KGaA
  • Astellas Pharma Inc
  • Takeda Pharmaceutical Company Limited
    		•